Why the study?
Does aspirin reduce the extent of atherosclerotic lesions in apolipoprotein-E-deficient mice fed a high-fat, high-cholesterol diet?
Does aspirin reduce the extent of atherosclerotic lesions in apolipoprotein-E-deficient mice fed a high-fat, high-cholesterol diet?
In a mouse model of atherosclerosis, aspirin showed a transitory protective effect on lesion initiation but did not prevent progression over longer periods on a high-fat diet.
Answers are grounded in this paper and cite their sources.
Aspirin shows only transient benefit in this mouse model; leaves open long-term effects and human translation.
Aspirin has potent antiinflammatory properties and attenuates atherosclerosis in apolipoprotein-E-deficient mice fed a high-fat, high-cholesterol diet. In an attempt to clarify the contradictory results obtained with normal chow, we studied the effect of aspirin for a prolonged period of time. The mice were fed a commercial chow until the experiment began at 8 weeks of age. Blood samples were then obtained and several mice (n=8) were sacrificed. The diet of the remaining 48 animals was supplemented with 200 g/kg palm fat and 1 g/kg cholesterol. They were then randomly divided into 2 groups, one of which received 0.5 mg/day of aspirin. The aspirin had a time-dependent effect. First, the extent of lesion decreased; then the effect was neutral; and, finally, after longer periods of being fed the atherogenic diet and receiving aspirin, the extent of the lesion increased. The transitory effect of aspirin should be elucidated in the absence of high dietary lipids.
No takes yet. Share an insight, caveat, or question.
Tous et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: